Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Mar;67(3):471–479. doi: 10.1038/bjc.1993.89

Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cells.

D R Shalinsky 1, D D Heath 1, A P Jekunen 1, J E Alcaraz 1, S B Howell 1
PMCID: PMC1968280  PMID: 8094975

Abstract

The ability of 1,9-dideoxyforskolin (DDF), 1-deoxyforskolin (DF) and forskolin to modulate cellular sensitivity to vinblastine (VBL) was examined in drug-sensitive parental KB-3-1 cells and a multidrug-resistant subline, KB-GRC1, derived by transfection of mdr1. Fifty microM DF and forskolin enhanced the 1 h uptake of VBL by 8.0 +/- 0.7 (s.d.) and 4.7 +/- 2.5-fold, respectively, with 50 microM DDF producing a 13.6 +/- 1.9-fold increase. The greater effect of DDF relative to forskolin indicated that the effect was independent of activation of cAMP, and this was supported by a lack of effect of dibutyryl cAMP on the uptake. The effect of these agents on uptake were < or = 1.4-fold in KB-3-1 cells. DDF selectively inhibited initial efflux in cells expressing a functional P-glycoprotein (PGP), but both forskolin and DDF inhibited the terminal phase of efflux irrespective of PGP expression. Neither agent affected membrane permeability of polarisation and forskolin did not enhance the uptake of VBL in protein-free liposomes. At a non-toxic concentration of 20 microM, DDF and forskolin decreased the IC50 of VBL from 18.9 to 2.7 and 13 nM in KB-GRC1 cells, respectively, and DDF acted synergistically with VBL as shown by median effect analysis [combination index = 0.20 +/- 0.05 (s.d.)]. In contrast, these diterpenes did not affect VBL sensitivity in KB-3-1 cells. These results indicate that the diterpenes modulate VBL sensitivity predominantly by inhibiting PGP-mediated efflux activity.

Full text

PDF
471

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham I., Chin K. V., Gottesman M. M., Mayo J. K., Sampson K. E. Transfection of a mutant regulatory subunit gene of cAMP-dependent protein kinase causes increased drug sensitivity and decreased expression of P-glycoprotein. Exp Cell Res. 1990 Jul;189(1):133–141. doi: 10.1016/0014-4827(90)90265-c. [DOI] [PubMed] [Google Scholar]
  2. Andrews P. A., Mann S. C., Huynh H. H., Albright K. D. Role of the Na+, K(+)-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells. Cancer Res. 1991 Jul 15;51(14):3677–3681. [PubMed] [Google Scholar]
  3. Cano-Gauci D. F., Busche R., Tümmler B., Riordan J. R. Fast kinetic analysis of drug transport in multidrug resistant cells using a pulsed quench-flow apparatus. Biochem Biophys Res Commun. 1990 Feb 28;167(1):48–53. doi: 10.1016/0006-291x(90)91728-b. [DOI] [PubMed] [Google Scholar]
  4. Chabner B. A., Fojo A. Multidrug resistance: P-glycoprotein and its allies--the elusive foes. J Natl Cancer Inst. 1989 Jun 21;81(12):910–913. doi: 10.1093/jnci/81.12.910. [DOI] [PubMed] [Google Scholar]
  5. Choi K. H., Chen C. J., Kriegler M., Roninson I. B. An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell. 1988 May 20;53(4):519–529. doi: 10.1016/0092-8674(88)90568-5. [DOI] [PubMed] [Google Scholar]
  6. Chou T. C., Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55. doi: 10.1016/0065-2571(84)90007-4. [DOI] [PubMed] [Google Scholar]
  7. Eastman A. Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II). Biochemistry. 1983 Aug 2;22(16):3927–3933. doi: 10.1021/bi00285a031. [DOI] [PubMed] [Google Scholar]
  8. Fine R. L., Patel J., Chabner B. A. Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci U S A. 1988 Jan;85(2):582–586. doi: 10.1073/pnas.85.2.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Greenberger L. M., Yang C. P., Gindin E., Horwitz S. B. Photoaffinity probes for the alpha 1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein. J Biol Chem. 1990 Mar 15;265(8):4394–4401. [PubMed] [Google Scholar]
  10. Hamada H., Hagiwara K., Nakajima T., Tsuruo T. Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: effects of verapamil, trifluoperazine, and phorbol esters. Cancer Res. 1987 Jun 1;47(11):2860–2865. [PubMed] [Google Scholar]
  11. Howell S. B., Isonishi S., Christen R. D., Andrews P. A., Mann S. Cellular pharmacologic strategies for overcoming drug resistance: potential applications to regional therapy. Eur J Surg Suppl. 1991 May;(561):45–48. [PubMed] [Google Scholar]
  12. Juranka P. F., Zastawny R. L., Ling V. P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J. 1989 Dec;3(14):2583–2592. doi: 10.1096/fasebj.3.14.2574119. [DOI] [PubMed] [Google Scholar]
  13. Krupinski J., Coussen F., Bakalyar H. A., Tang W. J., Feinstein P. G., Orth K., Slaughter C., Reed R. R., Gilman A. G. Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure. Science. 1989 Jun 30;244(4912):1558–1564. doi: 10.1126/science.2472670. [DOI] [PubMed] [Google Scholar]
  14. Laurenza A., Sutkowski E. M., Seamon K. B. Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action? Trends Pharmacol Sci. 1989 Nov;10(11):442–447. doi: 10.1016/S0165-6147(89)80008-2. [DOI] [PubMed] [Google Scholar]
  15. Mann S. C., Andrews P. A., Howell S. B. Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells. Int J Cancer. 1991 Jul 30;48(6):866–872. doi: 10.1002/ijc.2910480613. [DOI] [PubMed] [Google Scholar]
  16. Mellado W., Horwitz S. B. Phosphorylation of the multidrug resistance associated glycoprotein. Biochemistry. 1987 Nov 3;26(22):6900–6904. doi: 10.1021/bi00396a005. [DOI] [PubMed] [Google Scholar]
  17. Meyers M. B. Protein phosphorylation in multidrug resistant Chinese hamster cells. Cancer Commun. 1989;1(4):233–241. [PubMed] [Google Scholar]
  18. Morris D. I., Speicher L. A., Ruoho A. E., Tew K. D., Seamon K. B. Interaction of forskolin with the P-glycoprotein multidrug transporter. Biochemistry. 1991 Aug 27;30(34):8371–8379. doi: 10.1021/bi00098a014. [DOI] [PubMed] [Google Scholar]
  19. Robison G. A., Butcher R. W., Sutherland E. W. Cyclic AMP. Annu Rev Biochem. 1968;37:149–174. doi: 10.1146/annurev.bi.37.070168.001053. [DOI] [PubMed] [Google Scholar]
  20. Shalinsky D. R., Andreeff M., Howell S. B. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro. Cancer Res. 1990 Dec 1;50(23):7537–7543. [PubMed] [Google Scholar]
  21. Shalinsky D. R., Jekunen A. P., Alcaraz J. E., Christen R. D., Kim S., Khatibi S., Howell S. B. Regulation of initial vinblastine influx by P-glycoprotein. Br J Cancer. 1993 Jan;67(1):30–36. doi: 10.1038/bjc.1993.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Shalinsky D. R., Slovak M. L., Howell S. B. Modulation of vinblastine sensitivity by dipyridamole in multidrug resistant fibrosarcoma cells lacking mdr1 expression. Br J Cancer. 1991 Oct;64(4):705–709. doi: 10.1038/bjc.1991.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Staats J., Marquardt D., Center M. S. Characterization of a membrane-associated protein kinase of multidrug-resistant HL60 cells which phosphorylates P-glycoprotein. J Biol Chem. 1990 Mar 5;265(7):4084–4090. [PubMed] [Google Scholar]
  24. Thimmaiah K. N., Horton J. K., Qian X. D., Beck W. T., Houghton J. A., Houghton P. J. Structural determinants of phenoxazine type compounds required to modulate the accumulation of vinblastine and vincristine in multidrug-resistant cell lines. Cancer Commun. 1990;2(7):249–259. doi: 10.3727/095535490820874308. [DOI] [PubMed] [Google Scholar]
  25. Thimmaiah K. N., Sethi V. S. Chemical characterization of the degradation products of vinblastine dihydrogen sulfate. Cancer Res. 1985 Nov;45(11 Pt 1):5382–5385. [PubMed] [Google Scholar]
  26. Valverde M. A., Díaz M., Sepúlveda F. V., Gill D. R., Hyde S. C., Higgins C. F. Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein. Nature. 1992 Feb 27;355(6363):830–833. doi: 10.1038/355830a0. [DOI] [PubMed] [Google Scholar]
  27. Wadler S., Wiernik P. H. Partial reversal of doxorubicin resistance by forskolin and 1,9-dideoxyforskolin in murine sarcoma S180 variants. Cancer Res. 1988 Feb 1;48(3):539–543. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES